Borosil Renewables Limited’s Board of Directors convened on October 30, 2026, approving the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026. The board also sanctioned modifications to the Company’s Borosil Employee Stock Option Scheme 2017 (“ESOS 2017”), aiming to facilitate share allocation for option holders and extend the timeline for utilizing preferential issue proceeds. These decisions are subject to member and regulatory approvals.
Board Meeting Highlights
On October 30, 2026, Borosil Renewables Limited’s Board of Directors met to discuss and approve key corporate actions. The primary outcomes included the adoption of the unaudited financial results for both standalone and consolidated entities for the quarter and half-year concluding on September 30, 2026. These results, along with the Statutory Auditor’s Limited Review Reports, have been made available on the company’s website.
Employee Stock Option Scheme Amendments
The board also approved significant amendments to the company’s Borosil Employee Stock Option Scheme 2017 (“ESOS 2017”). These changes, aligned with SEBI regulations and the Companies Act, 2013, are designed to streamline the process of allotting shares to ESOS holders. Options will now be fulfilled through either primary issuance or secondary acquisition via a Trust route. Until the Trust is fully operational, the Scheme will be managed directly, with the company allotting fresh equity shares upon the valid exercise of vested options.
Preferential Issue Proceeds Timeline Extended
Further, the timeline for utilizing a portion of the proceeds from Preferential Issue – 2 was extended. Funds allocated for General Corporate Purposes will now be usable until March 31, 2027, an extension from the previous deadline of October 16, 2026, due to unforeseen operational exigencies. The Board meeting commenced at 1:30 p.m. (IST) and concluded at 3:25 p.m. (IST).
Source: BSE
